Wird geladen...

The Emerging Science of Precision Medicine and Pharmacogenomics for Parkinson’s Disease

Current therapies for Parkinson’s disease are problematic because they are symptomatic and have adverse effects. New drugs have failed in clinical trials due to inadequate efficacy. At the core of the problem is trying to make one drug work for all Parkinson’s disease patients, when we know this pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mov Disord
1. Verfasser: Payami, Haydeh
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5570630/
https://ncbi.nlm.nih.gov/pubmed/28686320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27099
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!